The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma
Wu, Y., Million, L., Moding, E. J., Scott, G., Berry, M., & Ganjoo, K. N. (2018). The Impact of Post-Operative Therapy on Primary Cardiac Sarcoma. The Journal of Thoracic and Cardiovascular Surgery.

Mice Lacking RIP3 Kinase are not Protected from Acute Radiation Syndrome
Castle, K. D., Daniel, A. R., Moding, E. J., Luo, L., Lee, C.-L., & Kirsch, D. G. (2018). Mice Lacking RIP3 Kinase are not Protected from Acute Radiation Syndrome. RADIATION RESEARCH, 189(6), 627–33.

Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era
Moding, E. J., Mowery, Y. M., & Kirsch, D. G. (2016). Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era. CANCER JOURNAL, 22(4), 267–73.

Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma
Lee, C.-L., Castle, K. D., Moding, E. J., Blum, J. M., Williams, N., Luo, L., … Kirsch, D. G. (2015). Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma. NATURE COMMUNICATIONS, 6, 8477.

Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy
Moding, E. J., Castle, K. D., Perez, B. A., Oh, P., Min, H. D., Norris, H., … Kirsch, D. G. (2015). Tumor cells, but not endothelial cells, mediate eradication of primary sarcomas by stereotactic body radiation therapy. SCIENCE TRANSLATIONAL MEDICINE, 7(278), 278ra34.

A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy
Liu, Y., Ashton, J. R., Moding, E. J., Yuan, H., Register, J. K., Fales, A. M., … Vo-Dinh, T. (2015). A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy. THERANOSTICS, 5(9), 946–60.

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer
Schoenhuber, N., Seidler, B., Schuck, K., Veltkamp, C., Schachtler, C., Zukowska, M., … Saur, D. (2014). A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer. NATURE MEDICINE, 20(11), 1340–47.

Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium
Moding, E. J., Lee, C.-L., Castle, K. D., Oh, P., Mao, L., Zha, S., … Kirsch, D. G. (2014). Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium. JOURNAL OF CLINICAL INVESTIGATION, 124(8), 3325–38.

Dual-Energy Micro-CT Functional Imaging of Primary Lung Cancer in Mice Using Gold and Iodine Nanoparticle Contrast Agents: A Validation Study
Ashton, J. R., Clark, D. P., Moding, E. J., Ghaghada, K., Kirsch, D. G., West, J. L., & Badea, C. T. (2014). Dual-Energy Micro-CT Functional Imaging of Primary Lung Cancer in Mice Using Gold and Iodine Nanoparticle Contrast Agents: A Validation Study. PLOS ONE, 9(2), e88129.

Strategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013). Strategies for optimizing the response of cancer and normal tissues to radiation. NATURE REVIEWS DRUG DISCOVERY, 12(7), 526–42.

In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT
Clark, D. P., Ghaghada, K., Moding, E. J., Kirsch, D. G., & Badea, C. T. (2013). In vivo characterization of tumor vasculature using iodine and gold nanoparticles and dual energy micro-CT. PHYSICS IN MEDICINE AND BIOLOGY, 58(6), 1683–1704.

A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models
Subashi, E., Moding, E. J., Cofer, G. P., MacFall, J. R., Kirsch, D. G., Qi, Y., & Johnson, G. A. (2013). A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models. MEDICAL PHYSICS, 40(2), 022304.

Dual-Energy Micro-Computed Tomography Imaging of Radiation-Induced Vascular Changes in Primary Mouse Sarcomas
Moding, E. J., Clark, D. P., Qi, Y., Li, Y., Ma, Y., Ghaghada, K., … Badea, C. T. (2013). Dual-Energy Micro-Computed Tomography Imaging of Radiation-Induced Vascular Changes in Primary Mouse Sarcomas. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 85(5), 1353–59.

Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice
Lee, C.-L., Moding, E. J., Huang, X., Li, Y., Woodlief, L. Z., Rodrigues, R. C., … Kirsch, D. G. (2012). Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice. DISEASE MODELS & MECHANISMS, 5(3), 397–402.

p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice
Lee, C.-L., Moding, E. J., Cuneo, K. C., Li, Y., Sullivan, J. M., Mao, L., … Kirsch, D. G. (2012). p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice. SCIENCE SIGNALING, 5(234), ra52.

An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer
Moding, E. J., Min, H. D., Castle, K. D., Ali, M., Woodlief, L., Williams, N., … Kirsch, D. G. (2016). An extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancer. JCI INSIGHT, 1(10).

p53 acts during total-body irradiation to promote lymphomagenesis
Lee, C.-L., Bium, J. M., Moding, E. J., Sullivan, J. M., Jeffords, L. B., Rodrigues, R. C., … Kirsch, D. G. (2012). p53 acts during total-body irradiation to promote lymphomagenesis. CANCER RESEARCH, 72.

Reining in Radiation Injury: HIF2 alpha in the Gut
Lee, C.-L., Moding, E. J., & Kirsch, D. G. (2014). Reining in Radiation Injury: HIF2 alpha in the Gut. SCIENCE TRANSLATIONAL MEDICINE, 6(236), 236fs20.

A dual energy CT study on vascular effects of gold nanoparticles in radiation therapy
Ashton, J. R., Hoye, J., Deland, K., Whitley, M., Qi, Y., Moding, E., … Badea, C. T. (2016). A dual energy CT study on vascular effects of gold nanoparticles in radiation therapy. MEDICAL IMAGING 2016-BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING, 9788.

Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting
Cheung, P. F., Neff, F., Neander, C., Bazarna, A., Savvatakis, K., Liffers, S.-T., … Siveke, J. T. (2018). Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. CANCER RESEARCH, 78(17), 4997–5010.

Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
Moding, E. J., Advani, R., Rosenberg, S. A., & Hoppe, R. T. (2018). Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 129(3), 507–12.

Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors.
Moding, E. J., Liang, R., Lartey, F. M., Maxim, P. G., Sung, A., Diehn, M., … Gensheimer, M. F. (2019). Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. Clinical Lung Cancer.

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC.
Hellmann, M. D., Nabet, B. Y., Rizvi, H., Chaudhuri, A. A., Wells, D. K., Dunphy, M. P., … Diehn, M. (2020). Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

Integrating genomic features for non-invasive early lung cancer detection.
Chabon, J. J., Hamilton, E. G., Kurtz, D. M., Esfahani, M. S., Moding, E. J., Stehr, H., … Diehn, M. (2020). Integrating genomic features for non-invasive early lung cancer detection. Nature, 580(7802), 245–251.

Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Nabet, B. Y., Esfahani, M. S., Moding, E. J., Hamilton, E. G., Chabon, J. J., Rizvi, H., … Diehn, M. (2020). Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell.

KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition.
Binkley, M. S., Jeon, Y.-J. J., Nesselbush, M., Moding, E. J., Nabet, B. Y., Almanza, D., … Diehn, M. (2020). KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discovery.

A mathematical model of ctDNA shedding predicts tumor detection size.
Avanzini, S., Kurtz, D. M., Chabon, J. J., Moding, E. J., Hori, S. S., Gambhir, S. S., … Reiter, J. G. (2020). A mathematical model of ctDNA shedding predicts tumor detection size. Science Advances, 6(50).

A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer
Nabet, B. Y., Esfahani, M. S., Hamilton, E. G., Chabon, J. J., Moding, E. J., Rizvi, H., … Diehn, M. (2020). A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity
Esfahani, M. S., Mehrmohamadi, M., Steen, C. B., Hamilton, E. G., King, D. A., Soo, J., … Alizadeh, A. A. (2020). Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.

The Ami and Yami aborigines of Taiwan and their genetic relationship to East Asian and Pacific populations.
Tatte, K., Metspalu, E., Post, H., Palencia-Madrid, L., Luis, J. R., Reidla, M., … Herrera, R. J. (2021). The Ami and Yami aborigines of Taiwan and their genetic relationship to East Asian and Pacific populations. European Journal of Human Genetics : EJHG.

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.
Kurtz, D. M., Soo, J., Co Ting Keh, L., Alig, S., Chabon, J. J., Sworder, B. J., … Alizadeh, A. A. (2021). Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature Biotechnology.

Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
Moding, E. J., Liu, Y., Nabet, B. Y., Chabon, J. J., Chaudhuri, A. A., Hui, A. B., … Diehn, M. (2020). Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer. Nature Cancer, 1(2), 176–183.

Liquid Biopsies for Molecular Biology-Based Radiotherapy.
Blomain, E. S., & Moding, E. J. (2021). Liquid Biopsies for Molecular Biology-Based Radiotherapy. International Journal of Molecular Sciences, 22(20).

Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease.
Moding, E. J., Nabet, B. Y., Alizadeh, A. A., & Diehn, M. (2021). Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. Cancer Discovery.

Inferring gene expression from cell-free DNA fragmentation profiles.
Esfahani, M. S., Hamilton, E. G., Mehrmohamadi, M., Nabet, B. Y., Alig, S. K., King, D. A., … Alizadeh, A. A. (2022). Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology.

Local control outcomes using stereotactic body radiotherapy or surgical resection for metastatic sarcoma.
Gutkin, P. M., von Eyben, R., Chin, A., Donaldson, S. S., Oh, J., Jiang, A., … Hiniker, S. M. (2022). Local control outcomes using stereotactic body radiotherapy or surgical resection for metastatic sarcoma. International Journal of Radiation Oncology, Biology, Physics.

Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomas.
Obeid, J.-P. P., Hiniker, S. M., Schroers-Martin, J., Guo, H. H., No, H. J., Moding, E. J., … Binkley, M. S. (2023). Investigating and modeling positron emission tomography factors associated with large cell transformation from low-grade lymphomas. EJHaem, 4(1), 90–99.

Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis.
Bui, N. Q., Nemat-Gorgani, N., Subramanian, A., Torres, I. A., Lohman, M., Sears, T. J., … Moding, E. J. (2023). Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

Investigating the tissue specificity and prognostic impact of cis-regulatory cancer risk variants.
Subramanian, A., Su, S., Moding, E. J., & Binkley, M. S. (2023). Investigating the tissue specificity and prognostic impact of cis-regulatory cancer risk variants. Human Genetics.

Characterizing the role of Phlda3 in the development of acute toxicity and malignant transformation of hematopoietic cells induced by total-body irradiation in mice.
Hasapis, S., Caraballo, I., Sears, T. J., Brock, K. D., Cart, J. B., Moding, E. J., & Lee, C.-L. (2023). Characterizing the role of Phlda3 in the development of acute toxicity and malignant transformation of hematopoietic cells induced by total-body irradiation in mice. Scientific Reports, 13(1), 12916.

Patterns of local recurrence and risk of skin recurrence in soft tissue sarcomas after surgical resection.
Ewongwo, A., Oladipo, E. D., Hui, C., Avedian, R. S., Steffner, R. J., Mohler, D. G., … Moding, E. J. (2023). Patterns of local recurrence and risk of skin recurrence in soft tissue sarcomas after surgical resection. Practical Radiation Oncology.

Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
No, H. J., Guo, F. B., Park, N. J.-I., Kastelowitz, N., Rhee, J.-W. W., Clark, D. E., … Binkley, M. S. (2023). Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer. JACC. CardioOncology, 5(6), 775–787.

Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma.
Su, C., Kent, C. L., Pierpoint, M., Floyd, W., Luo, L., Wiliams, N. T., … Kirsch, D. G. (2024). Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma. BioRxiv : the Preprint Server for Biology.

Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.
Subramanian, A., Nemat-Gorgani, N., Ellis-Caleo, T. J., van IJzendoorn, D. G., Sears, T. J., Somani, A., … Moding, E. J. (2024). Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy. Nature Cancer.

Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care.
Ewongwo, A., Hui, C., & Moding, E. J. (2024). Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care. Seminars in Radiation Oncology, 34(2), 195–206.

Effect of palliative radiation dose on symptom response in metastatic sarcomas.
Matsui, J. K., Jackson, S., Fang, J., Million, L., Chin, A. L., Hiniker, S. M., … Moding, E. J. (2024). Effect of palliative radiation dose on symptom response in metastatic sarcomas. Clinical and Translational Radiation Oncology, 48, 100803.

Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas.
Su, C., Kent, C. L., Pierpoint, M., Floyd, W., Luo, L., Williams, N. T., … Kirsch, D. G. (2024). Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas. JCI Insight, 9(14).

Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer.
Murciano-Goroff, Y. R., Hui, A. B.-Y., Araujo Filho, J. A., Hamilton, E. G., Chabon, J. J., Moding, E. J., … Diehn, M. (2024). Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung Cancer. JCO Precision Oncology, 8, e2400216.

56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice.
Finkelstein, S. R., Patel, R., Deland, K., Mercer, J., Starr, B., Zhu, D., … Kirsch, D. G. (2024). 56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice. Radiation Research.